Nurdan TÖZÜN et al. 2019. Safety of peginterferon alfa-2a (40KD) treatment in patients with chronic hepatitis B infection: An observational, multicenter, open label, non-interventional study in Turkish patients. Turkish Journal of Gastroenterology. 23, 5 (Jul. 2019), 552–559.